Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Medical Center Berbatov Ltd.

Verifiedinfo

Bulgaria Ulitsa Beli Drin 9, 8600 Yambol, Bulgaria

  • 7 trials recruiting
  • Obesity · Type 2 diabetes mellitus · Chronic kidney disease
  • Adult patients

About Specializations

Medical Center Berbatov Ltd. in Yambol, Bulgaria specialises in clinical trials of conditions such as Obesity, Type 2 diabetes mellitus, Chronic kidney disease, Graves' disease, and other specialisations. This site conducts important research.

Main research areas of the site

Endocrinology and Diabetes Management

The medical center is at the forefront of diabetes research, focusing on innovative treatment strategies for Type 2 Diabetes (T2D). The center's research aims to enhance glycemic control in patients whose condition is inadequately managed with current therapies.

  • Combination Therapy with Gliclazide MR and Dapagliflozin
  • Weekly Insulin Icodec vs. Daily Insulin Glargine

By exploring the efficacy of novel drug combinations and insulin regimens, the center contributes significantly to the development of more effective and patient-friendly diabetes management protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Beli Drin 98600 YambolBulgaria
Open in maps ↗
Recruiting now
7 trials
Conditions studied
7
Partner status
Verified

More sites in YambolBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

21 clinical trials

Type 2 diabetes mellitus

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Chronic kidney disease

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Graves' disease

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Type 2 diabetes mellitus

Recruiting
Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Graves' disease

Recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH

Chronic kidney disease+1

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Type 2 diabetes mellitus

Not yet recruiting
Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Obesity

Not yet recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.